Epigenomics: Mapping the Methylome

DNA methylation is integral to normal development and disease processes. However, the genomic distribution of methylated sequences – the methylome – is poorly understood. We have recently developed a platform technology for rapid assessment of methylation status throughout the human genome in a high-resolution, high-throughput manner. This is achieved by coupling a methylated DNA immunoprecipitation (MeDIP) method for isolating methyl cytosine rich fragments with array-based comparative genomic hybridization (array CGH). Using a combination of whole genome tiling path BAC arrays and CpG island microarrays, DNA methylation profiles are obtained simultaneously at both genome-wide and locus-specific levels. A comparison between male and female DNA using MeDIP-array CGH revealed unexpected hypomethylation of the inactive x-chromosome in gene-poor regions. Furthermore, comparisons between cancer and non-cancer cell types yielded differential methylation patterns that link genetic and epigenetic instability offering a new approach to decipher misregulation in cancer. Finally, we provide new data showing epigenomic instability in lung cancer cells with concurrent regions of genetic and epigenetic alterations harbouring known oncogenes.

[1]  S. Lam,et al.  High resolution analysis of non‐small cell lung cancer cell lines by whole genome tiling path array CGH , 2006, International journal of cancer.

[2]  Jun Yao,et al.  Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.

[3]  W. Lam,et al.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.

[4]  R. Gartenhaus,et al.  MSRE-PCR for analysis of gene-specific DNA methylation , 2005, Nucleic acids research.

[5]  Igor Jurisica,et al.  CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome , 2005, Nucleic acids research.

[6]  J. Fridlyand,et al.  Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3 , 2005, Nature Genetics.

[7]  D. Coppola,et al.  Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells , 2005, Cancer biology & therapy.

[8]  Patrick G Buckley,et al.  High‐resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas , 2005, Genes, chromosomes & cancer.

[9]  Manel Esteller,et al.  DNA methylation and cancer therapy: new developments and expectations , 2005, Current opinion in oncology.

[10]  Thomas E. Royce,et al.  Global Identification of Human Transcribed Sequences with Genome Tiling Arrays , 2004, Science.

[11]  Andrew P Feinberg,et al.  The epigenetics of cancer etiology. , 2004, Seminars in cancer biology.

[12]  Mark Groudine,et al.  Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells , 2004, Nature Structural &Molecular Biology.

[13]  F. Yamamoto,et al.  A DNA microarray-based methylation-sensitive (MS)-AFLP hybridization method for genetic and epigenetic analyses , 2004, Molecular Genetics and Genomics.

[14]  Bradley P. Coe,et al.  A tiling resolution DNA microarray with complete coverage of the human genome , 2004, Nature Genetics.

[15]  A. Niveleau,et al.  DNA methylation of the X chromosomes of the human female: an in situ semi-quantitative analysis , 1996, Chromosoma.

[16]  Calum MacAulay,et al.  SeeGH – A software tool for visualization of whole genome array comparative genomic hybridization data , 2004, BMC Bioinformatics.

[17]  Esteban Ballestar,et al.  Methyl‐CpG binding proteins identify novel sites of epigenetic inactivation in human cancer , 2003, The EMBO journal.

[18]  J. Sebat,et al.  Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. , 2003, Genome research.

[19]  B. Migeon.  X chromosome inactivation: theme and variations , 2003, Cytogenetic and Genome Research.

[20]  Tim Hui-Ming Huang,et al.  Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. , 2002, Cancer research.

[21]  Huidong Shi,et al.  Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. , 2002, Genome research.

[22]  C. M. Chen,et al.  Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. , 2001, Cancer research.

[23]  Rudolf Jaenisch,et al.  DNA hypomethylation leads to elevated mutation rates , 1998, Nature.

[24]  R. O’Neill,et al.  Undermethylation associated with retroelement activation and chromosome remodelling in an interspecific mammalian hybrid , 1998, Nature.

[25]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Schmid,et al.  Alu repeated DNAs are differentially methylated in primate germ cells. , 1994, Nucleic acids research.

[27]  A. Riggs,et al.  Differences in methylation on the active and inactive human X chromosomes , 1985, Annals of human genetics.

[28]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.